A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis
Vannucchi, Alessandro M, Kantarjian, Hagop M, Kiladjian, Jean-Jacques, Gotlib, Jason, Cervantes, Francisco, Mesa, Ruben A, Sarlis, Nicholas J, Peng, Wei, Sandor, Victor, Gopalakrishna, Prashanth, Hmissi, Abdel, Stalbovskaya, Viktoriya, Gupta, Vikas, Harrison, Claire, Verstovsek, Srdan
Published in Haematologica (Roma) (01.09.2015)
Published in Haematologica (Roma) (01.09.2015)
Get full text
Journal Article
BEACON CRC: a randomized, 3-Arm, phase 3 study of encorafenib and cetuximab with or without binimetinib vs. choice of either irinotecan or FOLFIRI plus cetuximab in BRAF V600E–mutant metastatic colorectal cancer
Kopetz, S., Grothey, A., Van Cutsem, E., Yaeger, R., Wasan, H., Yoshino, T., Desai, J., Ciardiello, F., Gollerkeri, A., Maharry, K., Loupakis, F., Hong, Y., Steeghs, N., Guren, T., Arkenau, H., García Alfonso, P., Sandor, V., Christy-Bittel, J., Anderson, L., Tabernero, J.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
P21-dependent G1 arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228
SANDOR, V, SENDEROWICZ, A, MERTINS, S, SACKETT, D, SAUSVILLE, E, BLAGOSKLONNY, M. V, BATES, S. E
Published in British journal of cancer (2000)
Published in British journal of cancer (2000)
Get full text
Journal Article
Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma
Sandor, V, Stark-Vancs, V, Pearson, D, Nussenblat, R, Whitcup, S M, Brouwers, P, Patronas, N, Heiss, J, Jaffe, E, deSmet, M, Kohler, D, Simon, R, Wittes, R
Published in Journal of clinical oncology (01.09.1998)
Published in Journal of clinical oncology (01.09.1998)
Get more information
Journal Article
Using the National Cancer Institute Anticancer Drug Screen to Assess the Effect of MRP Expression on Drug Sensitivity Profiles
Alvarez, M, Robey, R, Sandor, V, Nishiyama, K, Matsumoto, Y, Paull, K, Bates, S, Fojo, T
Published in Molecular pharmacology (01.11.1998)
Published in Molecular pharmacology (01.11.1998)
Get full text
Journal Article
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
Kopetz, Scott, Grothey, Axel, Yaeger, Rona, Van Cutsem, Eric, Desai, Jayesh, Yoshino, Takayuki, Wasan, Harpreet, Ciardiello, Fortunato, Loupakis, Fotios, Hong, Yong Sang, Steeghs, Neeltje, Guren, Tormod K, Arkenau, Hendrik-Tobias, Garcia-Alfonso, Pilar, Pfeiffer, Per, Orlov, Sergey, Lonardi, Sara, Elez, Elena, Kim, Tae-Won, Schellens, Jan H.M, Guo, Christina, Krishnan, Asha, Dekervel, Jeroen, Morris, Van, Calvo Ferrandiz, Aitana, Tarpgaard, L.S, Braun, Michael, Gollerkeri, Ashwin, Keir, Christopher, Maharry, Kati, Pickard, Michael, Christy-Bittel, Janna, Anderson, Lisa, Sandor, Victor, Tabernero, Josep
Published in The New England journal of medicine (24.10.2019)
Published in The New England journal of medicine (24.10.2019)
Get full text
Journal Article
SarCNU, a Nitrosourea Analog on a Day 1, 5, and 9 Oral Schedule: A Phase I and Pharmacokinetic Study in Patients With Advanced Solid Tumors
PANASCI, L, STINSON, S. F, SAUSVILLE, E, MELNYCHUK, D, SANDOR, V, MILLER, W. H, BATIST, G, PATENAUDE, F, BANGASH, N, PANARELLO, L, ALAOUI-JAMALI, M
Published in Journal of clinical oncology (15.01.2003)
Published in Journal of clinical oncology (15.01.2003)
Get full text
Journal Article
Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I
Verstovsek, Srdan, Mesa, Ruben A, Gotlib, Jason, Levy, Richard S, Gupta, Vikas, DiPersio, John F, Catalano, John V, Deininger, Michael W N, Miller, Carole B, Silver, Richard T, Talpaz, Moshe, Winton, Elliott F, Harvey, Jr, Jimmie H, Arcasoy, Murat O, Hexner, Elizabeth O, Lyons, Roger M, Raza, Azra, Vaddi, Kris, Sun, William, Peng, Wei, Sandor, Victor, Kantarjian, Hagop
Published in Haematologica (Roma) (01.04.2015)
Published in Haematologica (Roma) (01.04.2015)
Get full text
Journal Article
Expression of the multidrug resistance-associated protein gene in refractory lymphoma : Quantitation by a validated polymerase chain reaction assay
ZHAN, Z, SANDOR, V. A, GAMELIN, E, REGIS, J, DICKSTEIN, B, WILSON, W, FOJO, A. T, BATES, S. E
Published in Blood (15.05.1997)
Published in Blood (15.05.1997)
Get full text
Journal Article
Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I
Verstovsek, Srdan, Mesa, Ruben A, Gotlib, Jason, Levy, Richard S, Gupta, Vikas, DiPersio, John F, Catalano, John V, Deininger, Michael W N, Miller, Carole B, Silver, Richard T, Talpaz, Moshe, Winton, Elliott F, Harvey, Jr, Jimmie H, Arcasoy, Murat O, Hexner, Elizabeth O, Lyons, Roger M, Paquette, Ronald, Raza, Azra, Vaddi, Kris, Erickson-Viitanen, Susan, Sun, William, Sandor, Victor, Kantarjian, Hagop M
Published in Haematologica (Roma) (01.12.2013)
Published in Haematologica (Roma) (01.12.2013)
Get full text
Journal Article
LBA-006BEACON CRC: a randomized, 3-Arm, phase 3 study of encorafenib and cetuximab with or without binimetinib vs. choice of either irinotecan or FOLFIRI plus cetuximab in BRAF V600E–mutant metastatic colorectal cancer
Kopetz, S, Grothey, A, Van Cutsem, E, Yaeger, R, Wasan, H, Yoshino, T, Desai, J, Ciardiello, F, Gollerkeri, A, Maharry, K, Loupakis, F, Hong, Y, Steeghs, N, Guren, T, Arkenau, H, García Alfonso, P, Sandor, V, Christy-Bittel, J, Anderson, L, Tabernero, J
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Synchronous inflammatory breast cancer and advanced ovarian carcinoma: A case with prolonged disease-free survival
Sandor, V., Reed, E., Sarosy, G., Middleton, L. P., Davis, P., Kohn, E.
Published in Annals of oncology (01.05.1999)
Published in Annals of oncology (01.05.1999)
Get full text
Journal Article
1 MILO/ENGOT-OV11: Phase-3 study of binimetinib versus physician’s choice chemotherapy (PCC) in recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum
Grisham, R, Monk J, B, Banerjee, S, Coleman L, R, Oza M, A, Oehler K, M, Kalbacher, E, Mirza Raza, M, del Campo M, J, Marth, C, Westermann, A, Pignata, S, Colombo, N, Cibula, D, Hilpert, F, Aghajanian, C, Drill, E, Sandor, V, Boyd P, A, Vergote, I
Published in International journal of gynecological cancer (01.09.2019)
Published in International journal of gynecological cancer (01.09.2019)
Get full text
Journal Article
P21-dependent G arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228
Sandor, V, Senderowicz, A, Mertins, S, Sackett, D, Sausville, E, Blagosklonny, M V, Bates, S E
Published in British journal of cancer (01.09.2000)
Published in British journal of cancer (01.09.2000)
Get full text
Journal Article
Results of COLUMBUS Part 2: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) versus ENCO in BRAF-mutant melanoma
Dummer, R., Ascierto, P.A., Gogas, H., Arance, A., Mandala, M., Liszkay, G., Garbe, C., Schadendorf, D., Krajsová, I., Gutzmer, R., Chiarion Sileni, V., Dutriaux, C., de Groot, J.W.B., Yamazaki, N., Loquai, C., de Parseval, L.A., Pickard, M., Sandor, V., Robert, C., Flaherty, K.T.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Hospitalization Rates in COLUMBUS Part 1: A Phase 3 Trial of Encorafenib (ENCO) Plus Binimetinib (BINI) Versus Vemurafenib (VEM) or ENCO in BRAF-Mutant Melanoma
Arance, A., Dummer, R., Ascierto, P.A., Gogas, H., Mandala, M., Liszkay, G., Garbe, C., Schadendorf, D., Krajsová, I., Gutzmer, R., Chiarion Sileni, V., Dutriaux, C., de Groot, J.W.B., Yamazaki, N., Loquai, C., de Parseval, L.A., Pickard, M., Sandor, V., Robert, C., Flaherty, K.T.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article